Rexahn Pharmaceuticals (RNN) To Offer Common Stocks and Warrants
Tweet Send to a Friend
Up)
Rexahn Pharmaceuticals, Inc. (NYSE: RNN) intends to offer shares of its common stock and warrants to purchase common stock in an underwritten public offering. The shares of common stock and warrants are being offered as units. The offering is subject to market and other conditions, and there can be no assurances as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Rexahn also expects to grant the underwriters a 45-day option to purchase additional shares of common stock and warrants to cover over-allotments, if any.
Burrill LLC and Maxim Group LLC are acting as joint book-running mangers for the offering.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Burrill LLC and Maxim Group LLC are acting as joint book-running mangers for the offering.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Triple-S (GTS) Prices 5.4M Common Secondary Offering
- Rose Rock Midstream (RRMS) Files $500M Mixed Shelf; 12.5M Common Units for Holders
- Tesla Motors (TSLA) filed an automatic shelf registration
Create E-mail Alert Related Categories
Equity OfferingsRelated Entities
Maxim Group
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
